
Poly-D-lysine hydrobromide (MW 30000-70000)
CAS No. 27964-99-4
Poly-D-lysine hydrobromide (MW 30000-70000)( —— )
Catalog No. M35204 CAS No. 27964-99-4
Poly-D-lysine hydrobromide (MW 30000-70000) (Poly-D-lysine HBr) is an oral peptide CaSR agonist that eliminates proteinase K-resistant PrP from prion-infected SN56 neuroblastoma cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 29 | Get Quote |
![]() ![]() |
10MG | 46 | Get Quote |
![]() ![]() |
25MG | 90 | Get Quote |
![]() ![]() |
50MG | 144 | Get Quote |
![]() ![]() |
100MG | 205 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePoly-D-lysine hydrobromide (MW 30000-70000)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPoly-D-lysine hydrobromide (MW 30000-70000) (Poly-D-lysine HBr) is an oral peptide CaSR agonist that eliminates proteinase K-resistant PrP from prion-infected SN56 neuroblastoma cells.
-
DescriptionPoly-D-lysine hydrobromide (MW 30000-70000) is a synthetic polymeric substrate and is one of the most widely used substrate in neural cell culture. Poly-D-lysine hydrobromide (MW 30000-70000) removes proteinase K-resistant PrP from prion-infected SN56 neuroblastoma cells without affecting PrPC.
-
In VitroPoly-D-lysine is immunogenic in rabbits only when injected at low doses.The approximate concentration of Poly-D-lysine (PDL) needed to lower the amount of PrPres by 50% corresponds to ~0.8 μg/mL or 50 nM.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCaSR
-
RecptorCaSR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number27964-99-4
-
Formula Weight
-
Molecular Formula(C6H14N2O2)x.xHBr
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (Ultrasonic))
-
SMILES(C6H14N2O2)x.xHBr
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. HansVermeersch, et al. Immunogenicity of poly-D-lysine, a potential polymeric drug carrier. Journal of Controlled Release. Volume 32, Issue 3, 1 December 1994, Pages 225-229.
molnova catalog



related products
-
Cinacalcet hydrochlo...
A calcimimetic agent that acts as an allosteric activator of CaSR.
-
SB-423562
SB-423562 is a calcium-sensing receptor (CaSR) antagonist and can be used in studies about osteoporosis.
-
Evocalcet
Evocalcet has an activating effect on the calcium-sensing receptor (CaSR).